neuro42, Inc. is a medtech Company advancing futuristic technologies for screening, diagnosis, and targeted treatment of neurological conditions. The Company is developing and commercializing a portable MRI, robotic and AI platform, backed by over 30 patents, for point-of-care imaging and interventions under live image guidance. neuro42 is founded by a team of serial entrepreneurs and innovators with a mission to improve lives through its patient-centric solutions.

Visit Site